XML 29 R14.htm IDEA: XBRL DOCUMENT v3.6.0.2
NOTE 8 - STOCKHOLDERS' EQUITY
 12 Months Ended
Dec. 31, 2016
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
NOTE 8 - STOCKHOLDERS’ EQUITY

SHARE REPURCHASE PROGRAM

Pursuant to Asure’s stock repurchase plan, we may repurchase up to 450,000 shares of our common stock.  We have repurchased a total of 384,000 shares for approximately $5,000 over the life of the plan.  Management will periodically assess repurchasing additional shares, depending on our cash position, market conditions, financial covenants and other factors.  While the program remains in place, we did not repurchase any shares during 2016 or 2015.

STOCK AND STOCK OPTION PLANS

Asure has one active equity plan, the 2009 Equity Plan (the “2009 Plan”). The 2009 Plan provides for the issuance of non-qualified and incentive stock options to our employees and consultants. We generally grant stock options with exercise prices greater than or equal to the fair market value at the time of grant.  The options generally vest over three to four years and are exercisable for a period of five to ten years beginning with the date of grant.   Our shareholders approved an amendment to the 2009 Plan in June 2014 to increase the number of shares reserved under the plan from 1,200,000 to 1,400,000. We have a total of 614,000 options granted and outstanding pursuant to the 2009 Plan as of December 31, 2016.

We use the Black-Scholes option valuation model to value employee stock awards. We estimate stock price volatility based upon our historical volatility. Estimated option life and forfeiture rate assumptions are derived from historical data. For stock-based compensation awards with graded vesting, we recognize compensation expense using the straight-line amortization method.

Total compensation expense recognized in the Consolidated Statements of Comprehensive Loss for stock based awards was $226 and $409 for 2016 and 2015, respectively.

The following table summarizes the assumptions used to develop their fair value for 2016 and 2015:

 
  
Year Ended December 31,
  
 
  
2016
    
2015
  
Risk-free interest rate
    
.97
%
    
1.90
%
Expected volatility
    
0.38
      
0.59
  
Expected life in years
    
3.44
      
3.61
  
Dividend yield
    
-
      
-
  

As of December 31, 2016, Asure had reserved shares of common stock for future issuance as follows:

Options outstanding
    
614,000
  
Options available for future grant
    
200,000
  
Shares reserved
    
814,000
  

The following table summarizes activity under all Plans during 2016 and 2015.

 
Year Ended December 31, 2016
  
Year Ended December 31, 2015
  
 
    
Weighted
      
Weighted
  
 
    
Average
      
Average
  
 
    
Exercise
      
Exercise
  
 
Shares
  
Price
  
Shares
  
Price
  
Outstanding at the beginning of the year
    
640,000
    
$
4.40
      
735,000
    
$
3.51
  
Granted
    
454,000
      
6.70
      
257,000
      
5.76
  
Exercised
    
(278,000
)
    
2.69
      
(240,000
)
    
2.44
  
Canceled
    
(202,000
)
    
5.61
      
(112,000
)
    
5.88
  
Outstanding at the end of the year
    
614,000
    
$
6.47
      
640,000
    
$
4.40
  
Options exercisable at the end of the year
    
130,000
    
$
5.71
      
324,000
    
$
3.09
  
Weighted average fair value of options granted during the year
   $
1.53
             $
5.76
          

The following table summarizes the outstanding and exercisable options and their exercise prices as of December 31, 2016:

   
OPTIONS OUTSTANDING
  
OPTIONS EXERCISABLE
  
RANGE OF
EXERCISE PRICES
  
NUMBER
OUTSTANDING AT
DECEMBER 31, 2016
  
WEIGHTED-
AVERAGE
REMAINING CONTRACTUAL
LIFE (YEARS)
  
WEIGHTED-AVERAGE
EXERCISE PRICE
  
NUMBER EXERCISABLE
AND VESTED AT
DECEMBER 31, 2016
  
WEIGHTED-AVERAGE
EXERCISE PRICE
  
                       
 
$
1.68– 5.27
    
$
99,000
    
$
3.46
    
$
5.01
    
$
32,000
    
$
4.97
  
   
5.28 -- 6.33
      
314,000
      
3.66
      
5.57
      
82,000
      
5.86
  
   
6.34 – 9.00
      
201,000
      
4.61
      
8.61
      
16,000
      
6.42
  
                                               
 
$
1.68 -- 9.00
      
614,000
      
3.94
    
$
6.47
      
130,000
    
$
5.71
  

The aggregate intrinsic value of options outstanding and options exercisable is $1,302 and $365, respectively, at December 31, 2016.